Exception-Status Listing: A Critical Pathway to Heart Transplantation for Adults With Congenital Heart Diseases.

Heart transplantation allocation system adults with congenital heart disease exception-status listing heart transplantation

Journal

Journal of cardiac failure
ISSN: 1532-8414
Titre abrégé: J Card Fail
Pays: United States
ID NLM: 9442138

Informations de publication

Date de publication:
03 2022
Historique:
received: 10 06 2021
revised: 30 09 2021
accepted: 02 10 2021
pubmed: 21 10 2021
medline: 4 5 2022
entrez: 20 10 2021
Statut: ppublish

Résumé

Adults with congenital heart diseases may not be candidates for conventional therapies to control ventricular systolic dysfunction, including mechanical circulatory support, which moves potential heart-transplantation recipients to a listing status of higher priority. This results in longer waitlist times and greater mortality rates. Exception-status listing allows a pathway for this complex and anatomically heterogenous group of patients to be listed for heart transplantation at appropriately high listing status. Our study queried the United Network for Organ Sharing registry to evaluate trends in the use of exception-status listing among adults with congenital heart diseases awaiting heart transplantation. Uptrend in the use of exception-status listing precedes the new allocation system, but it has been greatest since changes were made in the allocation system. It continues to remain a vital pathway for adults with congenital heart disease (whose waitlist mortality rates are often not characterized adequately by using the waitlist-status criteria) timely access to heart transplantation.

Identifiants

pubmed: 34670174
pii: S1071-9164(21)00424-3
doi: 10.1016/j.cardfail.2021.10.004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

415-421

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Aniket S Rali (AS)

From the Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

Sagar Ranka (S)

Department of Cardiovascular Diseases, University of Kansas Medical Center, Kansas City, Kansas.

Jeremy A Mazurek (JA)

Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.

Marshall D Brinkley (MD)

From the Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

Ari Cedars (A)

Departments of Medicine and Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland.

Daniel Clark (D)

From the Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

Nhue Do (N)

Division of Pediatric Cardiac Surgery, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee.

Gina E Lazzara (GE)

Departments of Medicine and Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.

Lynn Punnoose (L)

From the Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

Emily Sandhaus (E)

From the Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

Ashish Shah (A)

Division of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.

Siva Taduru (S)

Department of Cardiovascular Diseases, University of Kansas Medical Center, Kansas City, Kansas.

Mark Wigger (M)

From the Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

Sandip Zalawadiya (S)

From the Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

Joseph Rogers (J)

Texas Heart Institute, Houston, Texas.

Joann Lindenfeld (J)

From the Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

Kelly Schlendorf (K)

From the Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

Jonathan N Menachem (JN)

From the Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: jonathan.n.menachem@vumc.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH